Strand Genomics' avadis Software Application Achieves GeneChip-Compatible Status With Affymetrix (Santa Clara, California) (AFFX) GeneChip(R) Microarray Platform
10/19/2005 5:11:26 PM
Bangalore [September 14, 2005] - Strand Life Sciences today announced that its avadis software application has achieved GeneChip-compatible status with the Affymetrix Inc. (Nasdaq: AFFX) GeneChip® microarray platform and that it has joined the Affymetrix GeneChip-compatible Applications Program, which provides customers with a broad spectrum of software solutions for biomedical research and development. As a GeneChip-compatible software provider, Strand Life Sciences is committed to seamlessly integrating its tool avadis with the Affymetrix GeneChip platform.
comments powered by